LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that David Haen, Vice President of Business Development, will participate in the “Risk-Reduced Models for the Biotech Industry” panel at the BIO 2008 International Convention in San Diego on June 18.
